Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Dual-action eye drop targeting both evaporative and inflammatory dry eye disease moving to Phase 3 Positive Phase 1b results for ocular surface pain candidate validate TRPV1 antagonist approach and strengthen confidence in ongoing Phase 2 study Combined poten…